Alexion Pharmaceuticals
Headquartered in Cheshire, Connecticut (USA), Alexion is global biopharmaceutical company focused on the development and delivery of life-transforming therapies for patients with severe and life-threatening rare disorders.
Financial Data
-
31st Dec 18 Source: Estimated
- €514.4 million turnover
- 400 employees
-
31st Dec 17 Source: Estimated
- €321.6 million turnover
- 300 employees
- 4 more years available »
Ranking
By Turnover
(€514.4 million)- 150th in Top Companies
- 22nd in Health
- 20th in Pharma
By Employees
(400)- 404th in Top Companies
- 64th in Health
- 41st in Pharma
- 400
- €514.4 million
Employees
- Shane Doyle Senior vice president
Latest News
- 1:00am Software company to create 100 jobs in Belfast
- 12:29am Half of the country ‘unaffordable’ for average buyer
- Jun 24 Sharp increase in business insolvencies in Northern Ireland since Brexit
- Jun 24 Bartra gets green light for high-rise office scheme in Dublin
- Jun 24 Bob & Berts to open eight new coffee shops in Scotland and North